Articles Posted in antibiotics resistant infections

antibiotic-resistant-300x199
The United States Centers for Disease Control and Prevention (CDC) has issued a report based on data from 4000 hospitalizations, which concludes that one in seven infections in acute care hospitals are caused by antibiotic resistant hospital infections.According to the findings, one in seven infections in acute care hospitals, related to catheters and surgeries, are caused by antibiotic-resistant bacteria. Many of the urgent serious antibiotic-resistant bacteria threaten patients while being treated in hospitals for other conditions. Of the 15 urgent serious antibiotic-resistant infections, seven are predominantly acquired in a healthcare setting.
The report highlights the major medical dilemma that antibiotic-resistant bacteria can make infections impossible treat. Antibiotic resistant infections increase patient deaths. In the United States, approximately 2 million persons become ill each year with antibiotic-resistant infections and approximately 23,000 die. The CDC compiled data in 2014 from the National Healthcare Safety Network; taking data on specific infections from 4,000,  short-term acute care hospitals, 501 long-term acute care hospitals and 1,135 inpatient rehabilitation facilities in all 50 states.Researchers found the likelihood of a patient becoming infected by any of the six most common bacteria was 12% for in-patient rehabilitation facilities, and 29% for long term acute care hospitals.

More than half of hospitalized patients are receiving antibiotic treatment on any given day, and one-quarter of that population has a hospital acquired infection, making them more likely to contract illnesses which are resistant to common antibiotic treatment.

Health experts say there is an urgent need to engage new methods of reducing the spread of these superbugs, including finding new ways of treating infections without the use of antibiotics. The National Institute of Allergy and Infectious Diseases (NIAID) recently awarded $5 million to fund research focused on bacterial infection treatments that do not involve the use of antibiotics..  –